An accompanying conference call will be hosted by Dan Myers, Chief Executive Officer and Rick Eiswirth, President and Chief Financial Officer to discuss the results
| ATLANTA, July 18, 2018 /PRNewswire/ -- Alimera Sciences (NASDAQ: ALIM), a leader in the commercialization and development of prescription ophthalmic pharmaceuticals, today announced that it will release its financial results for the second quarter ended June 30, 2018, after the close of the financial markets on Monday, July 30, 2018. An accompanying conference call will be hosted by Dan Myers, Chief Executive Officer and Rick Eiswirth, President and Chief Financial Officer to discuss the results. The call will be held at 9:00 AM ET, on Tuesday, July 31, 2018. Please refer to the information below for conference call dial-in information and webcast registration. Conference Details Conference date: Tuesday July 31, 2018 9:00 AM ET Conference dial-in: 877.269.7756 International dial-in: 201.689.7817 Conference Call Name: Alimera Sciences Second Quarter 2018 Results Call Webcast Registration: Click Here Following the live call, a replay will be available on the Company’s website, www.alimerasciences.com, under “Investor Relations.” About Alimera Sciences Alimera, founded in June 2003, is a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharmaceuticals. Alimera is presently focused on diseases affecting the back of the eye, or retina because these diseases are not well treated with current therapies and will affect millions of people in our aging populations. Alimera’s commitment to retina specialists and their patients is manifest in Alimera’s product portfolio. For more information, please visit www.alimerasciences.com.
For press inquiries: For investor inquiries: Katie Brazel CG Capital for Alimera Sciences for Alimera Sciences 404-317-8361 877-889-1972 kbrazel@bellsouth.net investorrelations@cg.capital
View original content with multimedia:http://www.prnewswire.com/news-releases/alimera-sciences-to-report-second-quarter-2018-results-july-30-2018-300682692.html SOURCE Alimera Sciences, Inc. |
Company Codes: NASDAQ-NMS:ALIM |
